Cargando…
Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development Meeting
The ability to successfully develop a safe and effective vaccine for the prevention of HIV infection has proven challenging. Consequently, alternative approaches to HIV infection prevention have been pursued, and there have been a number of successes with differing levels of efficacy. At present, on...
Autores principales: | Romano, Joseph W., Baum, Marc M., Demkovich, Zach R., Diana, Frank, Dobard, Charles, Feldman, Paul L., Garcia-Lerma, J. Gerardo, Grattoni, Alessandro, Gunawardana, Manjula, Ho, Duy-Khiet, Hope, Thomas J., Massud, Ivana, Milad, Mark, Moss, John A., Pons-Faudoa, Fernanda P., Roller, Shane, van der Straten, Ariane, Srinivasan, Selvi, Veazey, Ronald S., Zane, Doris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213003/ https://www.ncbi.nlm.nih.gov/pubmed/33913760 http://dx.doi.org/10.1089/aid.2021.0028 |
Ejemplares similares
-
Comparative Pharmacokinetics and Local Tolerance of Tenofovir Alafenamide (TAF) From Subcutaneous Implant in Rabbits, Dogs, and Macaques
por: Gatto, G. J., et al.
Publicado: (2022) -
Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP)
por: Johnson, Leah M., et al.
Publicado: (2019) -
Performance and Stability of Tenofovir Alafenamide Formulations within Subcutaneous Biodegradable Implants for HIV Pre-Exposure Prophylaxis (PrEP)
por: Li, Linying, et al.
Publicado: (2020) -
The effect of depot medroxyprogesterone acetate on tenofovir alafenamide in rhesus macaques
por: Daly, Michele B., et al.
Publicado: (2020) -
Pregnancy Outcomes in Pregnant Women with HIV on Tenofovir Disoproxil Fumarate (TDF) Compared to Tenofovir Alafenamide (TAF)
por: Thimm, Matthew A., et al.
Publicado: (2022)